FindTrial
Sign In

Comparing the cost and safety of Cisatracurium and Atracurium in patients undergoing Surgery

Cost Analysis and Safety comparison between cisatracurium and atracurium in patients undergoing general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051945
Enrollment
140
Registered
2023-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection Cisatracurium Route: Intravenous Dosage: 0.15mg/kg Frequency: during induction and maintainence of anaesthesia for surgeries within 2 hours: Non Depolarising Neuromuscular blo

Sponsors

Shri B M Patil Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age less than 70 years ASA I and ASA II Surgery less than 2 hours

Exclusion criteria

Exclusion criteria: Patients with known allergy to drugs to be used

Design outcomes

Primary

MeasureTime frame
To compare the cost analysis and safety of cisatracurium and atracuriumTimepoint: 2 hours—

Secondary

MeasureTime frame
NILTimepoint: 0—

Countries

India

Contacts

Public ContactArun Kumar TV

Shri B M Patil Medical College

drvijay8@gmail.com9844095250

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026